Bioasis Technologies Inc. operates as a biopharmaceutical company. The company utilizes its proprietary xB3 platform to deliver therapeutics across the blood-brain barrier and treat central nervous system disorders in areas of high unmet medical need. Bioasis Technologies Inc. is based in New Haven, Connecticut.
Frequently asked questions
What sector does biOasis Technologies Inc (BIOAF) operate in?
biOasis Technologies Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is biOasis Technologies Inc (BIOAF) current stock price?
As of the latest data, biOasis Technologies Inc stock price is $0.00, with a previous close of $0.00.
What is biOasis Technologies Inc (BIOAF) current market capitalization?
biOasis Technologies Inc market cap is approximately 7.94 thousand.
What is biOasis Technologies Inc (BIOAF) Earnings Per Share (EPS)?
The trailing EPS is -$0.01.
Does biOasis Technologies Inc (BIOAF) pay dividends?
No. biOasis Technologies Inc does not pay a dividend.
What is biOasis Technologies Inc (BIOAF) beta (volatility) score?
biOasis Technologies Inc has a beta of 156.145, indicating very high volatility compared to the market.